![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | C07K 16/24 | (2006.01) |
A61K 47/68 | (2017.08) | ||
A61K 47/68 | (2017.01) | ||
A61P 9/02 | (2018.01) | ||
A61K 39/395 | (2006.01) | ||
A61K 39/395 | (2013.01) | ||
A61P 37/02 | (2006.01) | ||
A61P 19/02 | (2018.01) | ||
A61P 19/02 | (2006.01) | ||
A61P 37/08 | (2018.01) | ||
A61P 37/06 | (2018.01) | ||
A61P 1/00 | (2006.01) | ||
A61P 1/04 | (2006.01) | ||
A61P 17/00 | (2018.01) | ||
A61P 7/06 | (2006.01) | ||
A61P 17/06 | (2018.01) | ||
A61P 9/02 | (2006.01) | ||
A61P 7/06 | (2018.01) | ||
A61P 11/00 | (2006.01) | ||
A61P 29/00 | (2018.01) | ||
A61P 43/00 | (2006.01) | ||
A61P 1/04 | (2018.01) | ||
A61P 1/12 | (2006.01) | ||
A61P 27/02 | (2018.01) | ||
A61P 29/00 | (2006.01) | ||
A61P 13/12 | (2018.01) | ||
A61P 37/08 | (2006.01) | ||
A61P 25/00 | (2018.01) | ||
C07K 16/24 | (2013.01) | ||
A61P 1/00 | (2018.01) | ||
A61P 17/14 | (2018.01) | ||
A61P 43/00 | (2018.01) | ||
A61P 37/02 | (2018.01) | ||
A61P 19/08 | (2018.01) | ||
A61P 31/04 | (2018.01) | ||
A61P 11/00 | (2018.01) | ||
A61P 11/06 | (2018.01) | ||
Y02A 50/30 | (2018.01) | ||
A61P 1/12 | (2018.01) |
(11) | Patento numeris | 3514176 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 17850230.8 |
Europos patento paraiškos padavimo data | 2017-09-08 | |
(97) | Europos patento paraiškos paskelbimo data | 2019-07-24 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2021-12-15 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/CN2017/101083 |
Data | 2017-09-08 |
(87) | Numeris | WO 2018/050028 |
Data | 2018-03-22 |
(30) | Numeris | Data | Šalis |
201610827097 | 2016-09-14 | CN |
(72) |
SONG, Nanmeng , CN
LIU, Jiawang , CN
YANG, Yaping , CN
YANG, Yang , CN
YANG, Dongge , CN
ZHANG, Hongjuan , CN
JIN, Mengxie , CN
|
(73) |
Beijing Hanmi Pharmaceutical Co., Ltd. ,
No.10 Tianzhu West Road
Tianzhu Airport Industrial Zone A
Shunyi District, Beijing 101312,
CN
|
(54) | ANTIBODY SPECIFICALLY BINDING TO IL-17A AND FUNCTIONAL FRAGMENT THEREOF |
ANTIBODY SPECIFICALLY BINDING TO IL-17A AND FUNCTIONAL FRAGMENT THEREOF |